Aerovate Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $74k | 29k | 2.51 |
| 2024-12-31 | $78k | 29k | 2.65 |
| 2024-09-30 | $61k | 29k | 2.09 |
| 2024-06-30 | $87k | 52k | 1.66 |
| 2024-03-31 | $915k | 31k | 29.57 |
| 2023-12-31 | $669k | 30k | 22.63 |
| 2023-09-30 | $401k | 30k | 13.57 |
| 2023-06-30 | $457k | 27k | 17.15 |
| 2023-03-31 | $497k | 25k | 20.17 |
| 2022-12-31 | $722k | 25k | 29.30 |
| 2022-09-30 | $394k | 24k | 16.59 |
| 2022-06-30 | $373k | 24k | 15.65 |
| 2022-03-31 | $603k | 33k | 18.35 |
| 2021-12-31 | $292k | 25k | 11.80 |
| 2021-09-30 | $519k | 25k | 20.98 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management